Lisata Therapeutics' significant beat on earnings estimates is likely to positively impact investor sentiment and potentially lead to a short-term increase in stock price, similar to the previous quarter's performance post-earnings announcement. However, the lack of revenue growth could temper some of the enthusiasm, hence the importance is not at the maximum. The confidence level reflects the historical reaction to earnings beats but also acknowledges the unpredictable nature of market reactions.